A world in which epidemics and pandemics are no longer a threat to humanity
CEPI (pronounced 'seppy') is helping the world better prepare for future epidemic and pandemic threats and is spearheading efforts to advance the 100 Days Mission.
Our mission
CEPI's mission is to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats so they can be accessible to all people in need.
Why we exist
CEPI was launched after the global response to the 2014-2016 West Africa Ebola epidemic fell tragically short and there was a consensus that a coordinated, international, and intergovernmental plan was needed to develop and deploy new vaccines to prevent future epidemics.
What we do
CEPI leverages its unique position within the global health and R&D ecosystems, building on its proven track record of bringing together public-sector, private-sector and academic partners to accelerate the development of vaccines against emerging viral threats.
CEPI 2.0 and the 100 Days Mission
CEPI’s 2022-2026 plan, known as CEPI 2.0, is helping the world to make the scientific progress needed to respond to the next Disease X threat with a new vaccine in just 100 days. This goal is known as the 100 Days Mission. It is embraced by leaders of the G7 and G20, and is widely recognised as an ambitious global collaborative effort.
CEPI’s commitment to equitable access
A commitment to equitable access is inscribed in CEPI’s DNA. It is core to CEPI’s vision of a world in which epidemics and pandemics are no longer a threat to humanity. Learn more about CEPI’s approach to enabling equitable access to the vaccines it supports.
